RSSCategory: Pharmaceuticals

Chinese group to acquire Australian vitamin firm Vitaco in A$314 mn deal

August 5, 2016

Australian vitamins maker Vitaco Holdings has caught the attention of a Chinese group led by drugmaker Shanghai Pharmaceuticals Holding Co Ltd and private equity firm Primavera Capital. An agreement between the two parties has been made for the complete sale […]

Continue Reading

‘Anti-evolution’ drugs against cancer cells targeted by scientists

July 22, 2016

Plans to develop new ‘anti-evolution’ drugs to stop tumor cells from developing resistance to treatment is the new strategy scientists are devising in the war on cancer. According to Britain’s Institute of Cancer Research (ICR), one of the world’s top […]

Continue Reading

Vietnamese pharmaceutical market to grow 13.8% by 2020, says report

July 22, 2016

Vietnam’s 2015 pharmaceutical market value of US$3.5 billion will grow to an estimated US$6.6 billion by 2020, with a compound annual growth rate of 13.8%, according to research and consulting firm GlobalData. According to the company’s latest report, the increasing […]

Continue Reading

Sanofi Pasteur’s dengue vaccine approved in Costa Rica

July 20, 2016

The National Ministry of Health of Costa Ricahas approved Sanofi Pasteur’s tetravalent dengue vaccine, Dengvaxia, making it the fifth country in the world to do so. Sanofi Pasteur’s dengue vaccine has already been approved in Mexico, Brazil, El Salvador and […]

Continue Reading

Pfizer commits to include addiction risks in opioid marketing

July 8, 2016

The city of Chicago and global pharmaceutical company Pfizer recently announced an agreement that commits the drugmakerto disclosing the serious risks of addiction in its marketing of prescription opioid painkillers. Prescription opioid abuse is blamed for nearly 19,000 deaths a […]

Continue Reading

Spain’s Almirall eyeing dermatology assets from Canada’s Valeant

July 6, 2016

Spanish pharmaceutical company Almirall is building up its skin treatments business and could be interested in acquiring dermatology assets from Canada’s Valeant Pharmaceuticals, according to the head of the Barcelona-based company. Valeant is also looking to divest various products as […]

Continue Reading

US Army-developed Zika vaccines work in mice after one shot

June 29, 2016

A promising preclinical study of two Zika vaccine candidates has been completed by the Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School, suggesting that an effective human vaccine […]

Continue Reading

Novel antibodies from infants may accelerate HIV vaccine dev’t

June 25, 2016

A team led by Dr. Julie Overbaugh, a member of the Human Biology Division at Fred Hutchinson Cancer Research Center, Seattle, was the first to look at isolate HIV-neutralizing antibodies from infants. Their study is the only one to find […]

Continue Reading

Decriminalization of drugs in the UK urged by health organizations

June 17, 2016

The Royal Society for Public Health and the Faculty of Public Health, two leading public health organizations in the United Kingdom, have called for the decriminalization of possession and personal use of all illegal drugs in the UK, saying that […]

Continue Reading

NICE green-lights Bristol’s new melanoma drug cocktail

June 17, 2016

The National Institute for Health and Care Excellence (NICE) has given Bristol-Myers Squibb’s Opdivo and Yervoy combination for melanoma immunotherapy treatment a rapid draft approval in record time. The approval comes just weeks after the new drug cocktail was licensed […]

Continue Reading